Systematic monitoring of retention in care in U.S.-based HIV care facilities

AIDS Care. 2020 Jan;32(1):113-118. doi: 10.1080/09540121.2019.1619660. Epub 2019 May 25.

Abstract

National guidelines recommend that HIV providers systematically monitor retention in care to identify and re-engage persons suboptimally in care. We described (1) U.S.-based outpatient HIV care facilities that systematically monitor retention in care, and (2) characteristics of patients attending facilities that monitored retention in care. We used data collected during 6/2014-5/2015 from the Medical Monitoring Project, an annual, cross-sectional survey that produces nationally representative estimates of characteristics of HIV-positive persons in medical care. We described systematic monitoring of retention in care among facilities and patients attending facilities providing this service using weighted percentages and 95% confidence intervals, and used Rao-Scott chi-square tests (p < .05) to assess differences by selected characteristics. Overall, 67% of facilities systematically monitored retention in care, and 81% of patients attended these facilities. Federally qualified health centers, community-based organizations, health departments, non-private practices, and Ryan White HIV/AIDS Program (RWHAP)-funded facilities were more likely to systematically monitor retention in care. Persons living in poverty, and those who were homeless or incarcerated, or injected drugs were more likely to attend facilities with this service. Although systematic monitoring of retention in care is accessible for many patients, improvements at other, non-RWHAP-funded facilities may help in reaching national prevention goals.

Keywords: HIV; care; retention; systematic monitoring.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Ambulatory Care Facilities / organization & administration*
  • Anti-HIV Agents / therapeutic use*
  • Cross-Sectional Studies
  • Female
  • Financial Management
  • HIV Infections / drug therapy*
  • Humans
  • Male
  • Retention in Care*
  • United States

Substances

  • Anti-HIV Agents